Quince Therapeutics, Inc.QNCXNASDAQ
Loading
P/FCF Ratio Over TimeContracting
Percentile Rank71
Studio
Year-over-Year Change

Price to free cash flow ratio

Latest
-2.52
↑ 89% vs avg
Percentile
P71
Within normal range
Streak
2 yr
Consecutive declineContracting
Average
-23.77
Historical baseline
PeriodValueYoY Change
2024-2.52-18.7%
2023-2.12-338.4%
2022-0.48+91.9%
2021-5.94+62.7%
2020-15.93+50.3%
2019-32.05+46.2%
2018-59.53+16.8%
2017-71.57-